SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: UPLOAD
Document Type: TEXT-EXTRACT
Date Filed: 2024-08-27
Accession Number: 0000000000-24-009751
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000000000024009751/filename2.txt

Chunk 0 of 1
Word Count: 251
Character Count: 1595

Document Content:

August 27, 2024

Jack Ross
Chief Executive Officer
Synergy CHC Corp.
865 Spring Street
Westbrook, ME 04092

Re: Synergy CHC Corp.
Amendment No. 2 to Registration Statement on Form S-1
Filed August 14, 2024
File No. 333-280556
Dear Jack Ross:

We have reviewed your amended registration statement and have the
following comment.

Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe a comment applies to your facts
and circumstances
or do not believe an amendment is appropriate, please tell us why in your
response.

After reviewing any amendment to your registration statement and the
information you
provide in response to this letter, we may have additional comments. Unless we
note otherwise,
any references to prior comments are to comments in our August 8, 2024 letter.

Amendment No. 2 to Registration Statement on Form S-1
Certain Relationships and Related Party Transactions, page 72

1. We note your revised disclosures in response to prior comment 6. Please
revise to disclose
whether there are default terms in place, including any rights and
remedies in the event
you do not receive payment in full on or before the repayment date.
August 27, 2024
Page 2

Please contact Tracie Mariner at 202-551-3744 or Vanessa Robertson at
you have questions regarding comments on the financial statements and related
matters. Please
contact Tamika Sheppard at 202-551-8346 or Joe McCann at 202-551-6262 with any
other
questions.

Sincerely,

Division of
Corporation Finance
Office of Life
Sciences
cc: Mike Bradshaw